Cart
sales@molnova.com
Xylometazoline hydrochloride
CAS No. 1218-35-5
Xylometazoline hydrochloride( Xylometazoline HCl | xylomethazoline )
Catalog No. M10820 CAS No. 1218-35-5
Xylometazoline Hydrochloride is an α-adrenoceptor agonist commonly used as nasal decongestant.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 41 | In Stock |
|
| 1G | 71 | In Stock |
|
Biological Information
-
Product NameXylometazoline hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionXylometazoline Hydrochloride is an α-adrenoceptor agonist commonly used as nasal decongestant.
-
DescriptionXylometazoline Hydrochloride is an α-adrenoceptor agonist commonly used as nasal decongestant.
-
In Vitro——
-
In Vivo——
-
SynonymsXylometazoline HCl | xylomethazoline
-
PathwayEndocrinology/Hormones
-
TargetAdrenergic Receptor
-
Recptorα1A-adrenergic receptor| α1B-adrenergic receptor| α1D-adrenergic receptor| α2A-adrenergic receptor| α2B-adrenergic receptor| α2C-adrenergic receptor
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number1218-35-5
-
Formula Weight280.84
-
Molecular FormulaC16H24N2·HCl
-
Purity>98% (HPLC)
-
SolubilityEthanol: 56 mg/mL (199.4 mM); Water: 56 mg/mL (199.4 mM); DMSO: 27 mg/mL (96.14 mM)
-
SMILESCC1=C(CC2=NCCN2)C(C)=CC(C(C)(C)C)=C1.[H]Cl
-
Chemical Name2-[(4-tert-butyl-2,6-dimethylphenyl)methyl]-4,5-dihydro-1H-imidazole hydrochloride
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Haenisch B, Fundam Clin Pharmacol, 2010, 24(6), 729-739.
molnova catalog
related products
-
Mirabegron
Mirabegron is a selective β3-adrenoceptor agonist with EC50 of 22.4 nM.
-
Ivabradine hydrochlo...
Ivabradine hydrochloride, a new If inhibitor with IC 50 of 2.9 μM, which is a pure heart rate lowering agent.
-
Yohimbine hydrochlor...
Yohimbine hydrochloride is an alpha 2-adrenoreceptor antagonist, blocking the pre- and postsynaptic alpha-2 adrenoreceptors and causing an increased release of noradrenaline and dopamine.
